New molecular signatures map the stepwise development of gastric cancer

-

 



Gastric cancer often develops through a gradual sequence of changes, beginning with superficial gastritis and advancing through chronic atrophic gastritis, intestinal metaplasia, and precancerous lesions before culminating in malignancy. Helicobacter pylori infection, responsible for nearly 90% of non-cardia gastric cancers, plays a central role in triggering this cascade. While eradication therapy reduces risk, the molecular events that connect infection to cancer progression remain poorly understood. Previous studies have focused on individual pathways such as inflammation or immune response but lacked an integrated perspective. Due to these challenges, a deeper investigation into the molecular signatures of H. pylori-related carcinogenesis is needed to guide prevention and risk prediction.

A research team from Peking University Cancer Hospital & Institute and collaborating institutions published (DOI: 10.20892/j.issn.2095-3941.2025.0077) their findings on September 2025 in Cancer Biology & Medicine. The study applied large-scale proteomic profiling and single-cell transcriptomic sequencing to human gastric tissues spanning multiple stages of disease. By integrating prospective follow-up data and population-level plasma proteomics, the researchers uncovered robust protein signatures linking H. pylori infection to gastric lesion progression and cancer risk. Their work provides both mechanistic insight and potential biomarkers for early identification of individuals most vulnerable to developing gastric cancer.

The investigation analyzed gastric tissue samples from 166 individuals in Linqu, a high-risk region in China, and 99 patients in Beijing, profiling over 4,200 proteins. From this dataset, 28 proteins were validated as key markers of H. pylori infection and gastric cancer, including up-regulated proteins such as OLFM4 and ENO1 and down-regulated proteins like GSN and IGFBP2. Single-cell RNA sequencing of 135,000 gastric cells revealed that these protein-encoding genes exhibited stage-specific expression shifts during the transition from normal epithelium to intestinal metaplasia and ultimately malignant cells. To test predictive utility, the team built a 15-protein tissue panel that stratified patients by cancer risk: those in the highest quartile had over seven-fold increased odds of progressing to neoplasia. Extending these findings, a four-protein circulating panel (OLFM4, ENO1, GSN, IGFBP2) was validated in the UK Biobank cohort of 48,529 participants. Individuals in the high-risk group were nearly four times more likely to develop gastric cancer compared to those in the lowest risk group. Together, these results highlight a reproducible molecular trajectory that may underlie infection-driven gastric carcinogenesis.

The establishment of tissue-based and circulating protein panels holds promise for transforming gastric cancer prevention strategies. Currently, endoscopic screening is costly and invasive, limiting widespread implementation, particularly in resource-constrained regions. Non-invasive blood-based markers could enable scalable, population-level screening to identify individuals who most urgently require follow-up. Beyond clinical applications, the molecular signatures identified in this study shed light on the fundamental biology of infection-induced cancer, offering potential drug targets for therapeutic intervention. As these biomarkers are further validated, they could form the basis of precision medicine approaches that intercept gastric cancer development at its earliest stages.

#ResearchChemistry, #ChemicalInnovation, #Science, #ScienceResearch, #ScientificResearch, #ResearchAndDevelopment, #ChemistryEducation, #ChemistryExperiments, #ChemistryLab, #ChemistryStudents, #ChemistryStudy, #OrganicChemistry, #InorganicChemistry, #PhysicalChemistry, #AnalyticalChemistry, #Biochemistry, #MaterialsChemistry, #TheoreticalChemistry, #AppliedChemistry, #MedicinalChemistry

Comments

Post a Comment

Popular posts from this blog

Avoiding prostate cancer screening increases risk of death

-
Image
  Men who consistently avoid prostate cancer screening appointments face a disproportionately higher risk of dying from the disease, finds research identifying a new high-risk group. An analysis of data from across seven countries from the world's largest prostate cancer screening study, the European Randomized study of Screening for Prostate Cancer (ERSPC), is presented this weekend at the European Association of Urology (EAU) Congress in Madrid. Prostate cancer is the most common form of cancer in men in 112 countries, with prevalence expected to double by 2040. If introduced on a national scale, prostate cancer screening programmes that measure levels of prostate-specific antigen (PSA) in the blood have the potential to give men earlier access to treatment, a better chance of being cured. They can also prevent costly treatment associated with advanced prostate cancer. Long-term follow-up data from the ERSPC consistently report that PSA screening programmes can lead to a 20% re...
Read more

EchoBack CAR T-cells could be a game changer in cancer immunotherapy

-
Image
  Imagine a super-charged immune cell that can launch a focused attack on stubborn solid tumors - a smart fighter that destroys cancer cells for days without tiring. USC biomedical engineers have made this concept a reality, crafting what they have named the "EchoBack CAR T-cell," which could soon be a game changer in the field of cancer immunotherapy . The work, published in the scientific journal Cell, is a groundbreaking new approach that could overcome major obstacles in treating tumors that are not usually candidates for immunotherapy, while keeping healthy tissue safe. Chimeric antigen receptor (CAR) T-cell therapy is a promising field of cancer treatment that has shown great success in treating bloodborne cancers such as leukemia. It is a highly customized therapy in which cancer-fighting T-cells are drawn directly from the blood of a patient and given genetic modifications to enhance their ability to target and kill cancerous cells. The USC Alfred E. Mann Department ...
Read more

The Role of Analytical Chemistry in Industry and Manufacturing

-
Image
Industry and the manufacturing sector use multiple analytical chemical methods, whether for new product development, processing, or quality control. This article outlines the research to be presented at Pittcon on the advances being made in analytical chemistry and their application in industry and manufacturing. Spectroscopy is a valuable analytical tool for a wide range of sectors. Several talks will focus on Raman spectroscopy as a highly versatile analytical tool, which can be used in chemical processing from laboratory to manufacturing. Raman spectroscopy’s use in polymer science to measure and control chemical processes is a particular focus. The technique is becoming increasingly relevant as chemical manufacturing expands to include new developments such as batch reactions, microreactors, flow synthesis, and continuous processes. Pittcon will hear examples of using Raman spectroscopy to improve process efficiency and predict reaction end-times and physical properties of chemical...
Read more